Cripto haploinsufficiency affects in vivo colon tumor development

Emilia Giorgio, Annamaria Liguoro, Luca D'Orsi, Sara Mancinelli, Antonio Barbieri, Giuseppe Palma, Claudio Arra, Giovanna L. Liguori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Colorectal cancer is one of the most common and aggressive cancers arising from alterations in various signaling pathways, such as the WNT, RAS-MAPK, PI3K and transforming growth factor-β (TGF-β) pathways. Cripto (also called Teratocarcinoma-derived growth factor), the original member of the vertebrate EGF-CFC family, plays a key role in all of these pathways and is deeply involved in early embryo development and cancer progression. The role of Cripto in colon and breast cancer, in particular, has been investigated, as it is still not clearly understood. In this article, we provide the first in vivo functional evidence of a role of Cripto in colon cancer development. We analyzed the effect of Cripto haploinsufficiency on colon tumor formation by treating Cripto heterozygous mice with the colonotropic carcinogen azoxymethane (AOM). Of note, in our model system, Cripto haploinsufficiency increased tumorigenesis. Moreover, we revealed a correlation between the differential AOM response found in wt and Cripto+/- mice and the expression levels of glucose regulated protein-78 (Grp78), a heat shock protein required for Cripto signaling pathways. We hypothesize that the balance between Cripto and Grp78 expression levels might be crucial in cancer development and may account for the increased tumorigenesis in Cripto heterozygous mice. In summary, our results highlight the heterogeneous effect of Cripto on tumorigenesis and the consequent high level of complexity in the Cripto regulatory pathway, whose imbalance causes tumors.

Original languageEnglish
Pages (from-to)31-40
Number of pages10
JournalInternational Journal of Oncology
Volume45
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Haploinsufficiency
Colon
Azoxymethane
Carcinogenesis
Neoplasms
Colonic Neoplasms
Teratocarcinoma
Transforming Growth Factors
Heat-Shock Proteins
Phosphatidylinositol 3-Kinases
Epidermal Growth Factor
Carcinogens
Embryonic Development
Vertebrates
Colorectal Neoplasms
Intercellular Signaling Peptides and Proteins
Breast Neoplasms

Keywords

  • Azoxymethane
  • Colon cancer
  • Cripto heterozygous mice

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Cripto haploinsufficiency affects in vivo colon tumor development. / Giorgio, Emilia; Liguoro, Annamaria; D'Orsi, Luca; Mancinelli, Sara; Barbieri, Antonio; Palma, Giuseppe; Arra, Claudio; Liguori, Giovanna L.

In: International Journal of Oncology, Vol. 45, No. 1, 2014, p. 31-40.

Research output: Contribution to journalArticle

Giorgio, Emilia ; Liguoro, Annamaria ; D'Orsi, Luca ; Mancinelli, Sara ; Barbieri, Antonio ; Palma, Giuseppe ; Arra, Claudio ; Liguori, Giovanna L. / Cripto haploinsufficiency affects in vivo colon tumor development. In: International Journal of Oncology. 2014 ; Vol. 45, No. 1. pp. 31-40.
@article{337cbb3d9e284f9094ed25b8b851a5a8,
title = "Cripto haploinsufficiency affects in vivo colon tumor development",
abstract = "Colorectal cancer is one of the most common and aggressive cancers arising from alterations in various signaling pathways, such as the WNT, RAS-MAPK, PI3K and transforming growth factor-β (TGF-β) pathways. Cripto (also called Teratocarcinoma-derived growth factor), the original member of the vertebrate EGF-CFC family, plays a key role in all of these pathways and is deeply involved in early embryo development and cancer progression. The role of Cripto in colon and breast cancer, in particular, has been investigated, as it is still not clearly understood. In this article, we provide the first in vivo functional evidence of a role of Cripto in colon cancer development. We analyzed the effect of Cripto haploinsufficiency on colon tumor formation by treating Cripto heterozygous mice with the colonotropic carcinogen azoxymethane (AOM). Of note, in our model system, Cripto haploinsufficiency increased tumorigenesis. Moreover, we revealed a correlation between the differential AOM response found in wt and Cripto+/- mice and the expression levels of glucose regulated protein-78 (Grp78), a heat shock protein required for Cripto signaling pathways. We hypothesize that the balance between Cripto and Grp78 expression levels might be crucial in cancer development and may account for the increased tumorigenesis in Cripto heterozygous mice. In summary, our results highlight the heterogeneous effect of Cripto on tumorigenesis and the consequent high level of complexity in the Cripto regulatory pathway, whose imbalance causes tumors.",
keywords = "Azoxymethane, Colon cancer, Cripto heterozygous mice",
author = "Emilia Giorgio and Annamaria Liguoro and Luca D'Orsi and Sara Mancinelli and Antonio Barbieri and Giuseppe Palma and Claudio Arra and Liguori, {Giovanna L.}",
year = "2014",
doi = "10.3892/ijo.2014.2412",
language = "English",
volume = "45",
pages = "31--40",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Cripto haploinsufficiency affects in vivo colon tumor development

AU - Giorgio, Emilia

AU - Liguoro, Annamaria

AU - D'Orsi, Luca

AU - Mancinelli, Sara

AU - Barbieri, Antonio

AU - Palma, Giuseppe

AU - Arra, Claudio

AU - Liguori, Giovanna L.

PY - 2014

Y1 - 2014

N2 - Colorectal cancer is one of the most common and aggressive cancers arising from alterations in various signaling pathways, such as the WNT, RAS-MAPK, PI3K and transforming growth factor-β (TGF-β) pathways. Cripto (also called Teratocarcinoma-derived growth factor), the original member of the vertebrate EGF-CFC family, plays a key role in all of these pathways and is deeply involved in early embryo development and cancer progression. The role of Cripto in colon and breast cancer, in particular, has been investigated, as it is still not clearly understood. In this article, we provide the first in vivo functional evidence of a role of Cripto in colon cancer development. We analyzed the effect of Cripto haploinsufficiency on colon tumor formation by treating Cripto heterozygous mice with the colonotropic carcinogen azoxymethane (AOM). Of note, in our model system, Cripto haploinsufficiency increased tumorigenesis. Moreover, we revealed a correlation between the differential AOM response found in wt and Cripto+/- mice and the expression levels of glucose regulated protein-78 (Grp78), a heat shock protein required for Cripto signaling pathways. We hypothesize that the balance between Cripto and Grp78 expression levels might be crucial in cancer development and may account for the increased tumorigenesis in Cripto heterozygous mice. In summary, our results highlight the heterogeneous effect of Cripto on tumorigenesis and the consequent high level of complexity in the Cripto regulatory pathway, whose imbalance causes tumors.

AB - Colorectal cancer is one of the most common and aggressive cancers arising from alterations in various signaling pathways, such as the WNT, RAS-MAPK, PI3K and transforming growth factor-β (TGF-β) pathways. Cripto (also called Teratocarcinoma-derived growth factor), the original member of the vertebrate EGF-CFC family, plays a key role in all of these pathways and is deeply involved in early embryo development and cancer progression. The role of Cripto in colon and breast cancer, in particular, has been investigated, as it is still not clearly understood. In this article, we provide the first in vivo functional evidence of a role of Cripto in colon cancer development. We analyzed the effect of Cripto haploinsufficiency on colon tumor formation by treating Cripto heterozygous mice with the colonotropic carcinogen azoxymethane (AOM). Of note, in our model system, Cripto haploinsufficiency increased tumorigenesis. Moreover, we revealed a correlation between the differential AOM response found in wt and Cripto+/- mice and the expression levels of glucose regulated protein-78 (Grp78), a heat shock protein required for Cripto signaling pathways. We hypothesize that the balance between Cripto and Grp78 expression levels might be crucial in cancer development and may account for the increased tumorigenesis in Cripto heterozygous mice. In summary, our results highlight the heterogeneous effect of Cripto on tumorigenesis and the consequent high level of complexity in the Cripto regulatory pathway, whose imbalance causes tumors.

KW - Azoxymethane

KW - Colon cancer

KW - Cripto heterozygous mice

UR - http://www.scopus.com/inward/record.url?scp=84902588983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902588983&partnerID=8YFLogxK

U2 - 10.3892/ijo.2014.2412

DO - 10.3892/ijo.2014.2412

M3 - Article

C2 - 24805056

AN - SCOPUS:84902588983

VL - 45

SP - 31

EP - 40

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 1

ER -